Exhibit 23.5

Date: September 21, 2016

China Cord Blood Corporation
48th Floor, Bank of China Tower
1 Garden Road

Central Hong Kong S.A.R.

Madams and Sirs,

We hereby consent to the use of our name under the captions “Enforceability of Civil Liabilities”, “Legal Matters” and “Experts” in the registration statement on Form F3 (the “Registration Statement”) filed by China Cord Blood Corporation (the “Company”) with the U.S. Securities and Exchange Commission (the “SEC”) on or about the date hereof under the United States Securities Act of 1933, as amended (the “Securities Act”), and under the captions “Risk Factors”, “History and Current Business” and “Regulation” in the Annual Report on Form 20-F for the fiscal year ended March 31, 2016, filed with the SEC on July 28, 2016, incorporated by reference in the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act, or the regulations promulgated thereunder.